Tuo Deng, Ph.D.
Ph.D. in Biology, Tsinghua University School of Medicine, Beijing, China
Postdoctoral Research Fellow with Dr. Willa Hsueh, Diabetes Research Center, The Methodist Hospital Research Institute, Houston, USA.
Deng T, Shan S, Li PP, Shen ZF, Lu XP, Cheng J, Ning ZQ. “Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of Sp1”. Endocrinology 2006, 147(2):875-884
Deng T, Shan S, Li ZB, Wu ZW, Liao CZ, Ko B, Lu XP, Cheng J, Ning ZQ. “A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice”. Biological & Pharmaceutical Bulletin 2005, 28(7):1192-1196
Deng T, Ning ZQ, Zhou YX, Cheng J. “Application of biochip technology in drug discovery and development”. Chinese Journal of New Drugs 2002, 11(1):23-31
Liao CZ, Deng T, Shan S, Pan DS, Li ZB, Ning ZQ,Hu WM,Shi LM, Zhou JJ, Lu XP. “Current strategies in research of anti-diabetics by employment of PPAR as a target”. Chinese Journal of New Drugs 2003, 12(12):980-983
Liu L, Ning ZQ, Shan S, Zhang K, Deng T, Lu XP, Cheng YY. “Phthalide lactones from ligusticum chuanxiong inhibit lipopolysaccharide-induced TNF-a production and TNF-a-mediated NF-kB activation”. Planta Medica 2005, 71(9):808-813
Deng T. “Diabetes from Bench to Bedside: Understanding the Epidemic”. The Cardiology Report 2008, 5(1):5-15
Chen A, Luo M, Yuan G, Yu J, Deng T, Zhang L, Zhou Y, Mitchelson K, Cheng J. “Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells”. Biotechnol Lett 2008 Jul 22.